Bionano Genomics Stock Target Price and Analyst Consensus

BNGO Stock  USD 3.67  0.02  0.55%   
The current analyst and expert consensus on Bionano Genomics is Buy, with no strong buy opinions. The current projected Bionano Genomics target price consensus is 7.33 with 4 analyst opinions. Check out Macroaxis Advice on Bionano Genomics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.
The most common way Bionano Genomics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Bionano Genomics executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Bionano Genomics. We encourage you to use your own analysis of Bionano Genomics to validate this buy or sell advice. Bionano Genomics buy-or-sell recommendation module provides average expert sentiment on the projected Bionano Genomics target price to derive its highest and lowest estimates based on projected price volatility of 7.4388.
Lowest Forecast
6.67
Highest Forecast
8.14
Target Price
7.33
As of the 2nd of June 2025, Gross Profit is likely to drop to about 361 K. In addition to that, Pretax Profit Margin is likely to drop to -3.82. At this time, Bionano Genomics' Non Current Assets Total are very stable compared to the past year. As of the 2nd of June 2025, Net Receivables is likely to grow to about 5.6 M, while Short and Long Term Debt Total is likely to drop about 25.4 M.
It's important to approach Bionano Genomics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Bionano Genomics price targets

Bionano Genomics' stock target price is an estimate of its future price, usually made by analysts. Using Bionano Genomics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Bionano Genomics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Bionano Genomics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Bionano Genomics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Bionano Genomics is a key component of Bionano Genomics valuation and have some predictive power on the future returns of a Bionano Genomics.
Hype
Prediction
LowEstimatedHigh
0.183.6311.07
Details
Intrinsic
Valuation
LowRealHigh
0.224.4511.89
Details
Naive
Forecast
LowNextHigh
0.083.9311.36
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-2.93-2.93-2.93
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bionano Genomics. Your research has to be compared to or analyzed against Bionano Genomics' peers to derive any actionable benefits. When done correctly, Bionano Genomics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Bionano Genomics.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Corporate ETFs Idea
Corporate ETFs
Invested over 100 shares
Treasury ETFs Idea
Treasury ETFs
Invested over 500 shares
Sector ETFs Idea
Sector ETFs
Invested over 500 shares
Agency Mbs ETFs Idea
Agency Mbs ETFs
Invested over 100 shares
Macroaxis Index Idea
Macroaxis Index
Invested over 100 shares
Broad Debt ETFs Idea
Broad Debt ETFs
Invested over 60 shares
Investment Grade ETFs Idea
Investment Grade ETFs
Invested over 70 shares
When determining whether Bionano Genomics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bionano Genomics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bionano Genomics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bionano Genomics Stock:
Check out Macroaxis Advice on Bionano Genomics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Bionano Stock, please use our How to Invest in Bionano Genomics guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.